Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury
- 1 August 2016
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 282, 49-55
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01 NS42888, R01 NS54962, R21NS087467)
This publication has 42 references indexed in Scilit:
- Advances in the diagnosis, pathogenesis and treatment of CIDPNature Reviews Neurology, 2011
- Anti-Ganglioside Antibody-Mediated Activation of RhoA Induces Inhibition of Neurite OutgrowthJournal of Neuroscience, 2011
- Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathyProceedings of the National Academy of Sciences, 2009
- Identification of a receptor required for the anti-inflammatory activity of IVIGProceedings of the National Academy of Sciences, 2008
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG FcScience, 2008
- Shortage of human intravenous immunoglobulin—reasons and possible solutionsNature Clinical Practice Neurology, 2007
- Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc ReceptorScience, 2001
- In vivoAdministration of Intravenous Immunoglobulin (IVIg) can Lead to Enhanced Erythrocyte SequestrationJournal of Autoimmunity, 1999
- Acute motor axonal neuropathy: An antibody‐mediated attack on axolemmaAnnals of Neurology, 1996
- Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in ChinaAnnals of Neurology, 1993